Resmed Inc logo

RMD - Resmed Inc News Story

$193.54 -1.5  -0.7%

Last Trade - 18/05/21

Large Cap
Market Cap £20.08bn
Enterprise Value £20.43bn
Revenue £2.19bn
Position in Universe 451st / 6846

ResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021

Thu 8th April, 2021 9:05pm
For best results when printing this announcement, please click on link below:

SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD)
today announced it plans to release financial and operational results for the
third quarter of fiscal year 2021 on Thursday, April 29, 2021, after the New
York Stock Exchange closes. Following the release, ResMed management will host
a webcast to discuss these results. Other forward-looking and material
information may also be discussed during this webcast.

Earnings webcast details:

 • Location:                  
 • Date:               Thursday, April 29, 2021                   
 • Time:               1:30 p.m. PDT / 4:30 p.m. EDT              
 • International:      London, Thursday, April 29, 9:30 p.m. BST  
                       Sydney, Friday, April 30, 6:30 a.m. AEST   

Please note that ResMed does not use outside phone lines to access the
earnings call.

A replay of the earnings webcast will be accessible on ResMed’s website and
available approximately two hours after the webcast. In addition, a phone
replay will be available approximately two hours after the webcast and will be
accessible from April 29 until May 13 at:
* U.S.: +1 800.585.8367
* International: +1 416.621.4642
* Conference ID: 7757454
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and
keep people out of the hospital, empowering them to live healthier,
higher-quality lives. Our digital health technologies and cloud-connected
medical devices transform care for people with sleep apnea, COPD, and other
chronic diseases. Our comprehensive out-of-hospital software platforms support
the professionals and caregivers who help people stay healthy in the home or
care setting of their choice. By enabling better care, we improve quality of
life, reduce the impact of chronic disease, and lower costs for consumers and
healthcare systems in more than 140 countries. To learn more, visit
and follow @ResMed.

 For investors  Amy Wakeham +1 858.836.5000    For media Jayme Rubenstein +1 858.836.6798  


GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.